Logo image of BDSX

BIODESIX INC (BDSX) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:BDSX - US09075X2071 - Common Stock

9.66 USD
-0.67 (-6.49%)
Last: 1/29/2026, 6:15:57 PM
9.2 USD
-0.46 (-4.76%)
After Hours: 1/29/2026, 6:15:57 PM
Fundamental Rating

3

BDSX gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 103 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of BDSX have multiple concerns. BDSX is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • BDSX had negative earnings in the past year.
  • BDSX had a negative operating cash flow in the past year.
  • BDSX had negative earnings in each of the past 5 years.
  • BDSX had a negative operating cash flow in each of the past 5 years.
BDSX Yearly Net Income VS EBIT VS OCF VS FCFBDSX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M

1.2 Ratios

  • The Return On Assets of BDSX (-44.56%) is worse than 85.44% of its industry peers.
Industry RankSector Rank
ROA -44.56%
ROE N/A
ROIC N/A
ROA(3y)-55.74%
ROA(5y)-49.96%
ROE(3y)-553.97%
ROE(5y)-391.42%
ROIC(3y)N/A
ROIC(5y)N/A
BDSX Yearly ROA, ROE, ROICBDSX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800 -1K

1.3 Margins

  • Looking at the Gross Margin, with a value of 79.82%, BDSX belongs to the top of the industry, outperforming 94.17% of the companies in the same industry.
  • BDSX's Gross Margin has been stable in the last couple of years.
  • The Profit Margin and Operating Margin are not available for BDSX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 79.82%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y21.1%
GM growth 5Y0.76%
BDSX Yearly Profit, Operating, Gross MarginsBDSX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

2

2. Health

2.1 Basic Checks

  • BDSX does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, BDSX has more shares outstanding
  • BDSX has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for BDSX is higher compared to a year ago.
BDSX Yearly Shares OutstandingBDSX Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
BDSX Yearly Total Debt VS Total AssetsBDSX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

  • Based on the Altman-Z score of -7.34, we must say that BDSX is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -7.34, BDSX is doing worse than 86.41% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -7.34
ROIC/WACCN/A
WACC12.14%
BDSX Yearly LT Debt VS Equity VS FCFBDSX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M

2.3 Liquidity

  • BDSX has a Current Ratio of 1.84. This is a normal value and indicates that BDSX is financially healthy and should not expect problems in meeting its short term obligations.
  • BDSX has a better Current ratio (1.84) than 73.79% of its industry peers.
  • BDSX has a Quick Ratio of 1.84. This is a normal value and indicates that BDSX is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.84, BDSX is in the better half of the industry, outperforming 77.67% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.84
Quick Ratio 1.84
BDSX Yearly Current Assets VS Current LiabilitesBDSX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

7

3. Growth

3.1 Past

  • BDSX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 28.72%, which is quite impressive.
  • Looking at the last year, BDSX shows a very strong growth in Revenue. The Revenue has grown by 22.29%.
  • The Revenue has been growing by 23.78% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)28.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%17.14%
Revenue 1Y (TTM)22.29%
Revenue growth 3Y9.37%
Revenue growth 5Y23.78%
Sales Q2Q%19.93%

3.2 Future

  • BDSX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 20.43% yearly.
  • BDSX is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 23.14% yearly.
EPS Next Y17.09%
EPS Next 2Y23.9%
EPS Next 3Y20.43%
EPS Next 5YN/A
Revenue Next Year20.62%
Revenue Next 2Y23.68%
Revenue Next 3Y23.14%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
BDSX Yearly Revenue VS EstimatesBDSX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M 100M
BDSX Yearly EPS VS EstimatesBDSX Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 -10 -20 -30

1

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for BDSX. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for BDSX. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BDSX Price Earnings VS Forward Price EarningsBDSX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BDSX Per share dataBDSX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10

4.3 Compensation for Growth

  • BDSX's earnings are expected to grow with 20.43% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y23.9%
EPS Next 3Y20.43%

0

5. Dividend

5.1 Amount

  • BDSX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

BIODESIX INC / BDSX FAQ

Can you provide the ChartMill fundamental rating for BIODESIX INC?

ChartMill assigns a fundamental rating of 3 / 10 to BDSX.


What is the valuation status of BIODESIX INC (BDSX) stock?

ChartMill assigns a valuation rating of 1 / 10 to BIODESIX INC (BDSX). This can be considered as Overvalued.


Can you provide the profitability details for BIODESIX INC?

BIODESIX INC (BDSX) has a profitability rating of 1 / 10.


Can you provide the financial health for BDSX stock?

The financial health rating of BIODESIX INC (BDSX) is 2 / 10.